Updated 3-year #OS data with #Durvalumab from TOPAZ-1 presented at #ccfac24 .

👉🏼Median follow-up 43 months
👉🏼Updated HR 0.74
👉🏼OS rate at 36 months doubled: 7% (placebo) -> 15% (durvalumab)

Long-term survivors in #CCA are becoming a #reality .

Angela Lamarca Mitesh Borad, M.D.

News—
T-DXd Granted First-Ever Tissue-Agnostic ADC Approval.
bit.ly/3UhJhKO

Excited to share our paper in Annals of Vascular Surgery titled “In the Loop: Endovascular Pedal Arch Revascularization”

Nii-Kabu Kabutey UCIrvine Vascular Surgery UCI Health #PAD #CLTI #Revasc
#limbsalvage

annalsofvascularsurgery.com/article/S0890-…

🚨 Just in time for AACR #AACR24 Another major milestone in #TissueAgnostic #PrecisionMedicine 🙌🏼 First ADC tissue agnostic drug approved 🙌🏼
🚨FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumors…

Current wellness chief (Stephanie Chen) 🤝 new wellness chief (@NicoleMFierroMD) + 🐶

.Emily Siegel, MD nicely presents strategies to improve survivorship care for SGM cancer pts #SSO2024 Society of Surgical Oncology

During the #SSO2024 James Ewing Featured Lecture, our Dr. Funda Meric-Bernstam talks about the rapidly evolving precision oncology and implementation strategies for bench to bedside translation. Society of Surgical Oncology Kelly K Hunt #EndCancer

Congratulations and welcome to our incoming intern class!! We cannot wait to work with you and see you thrive!!
Farin Amersi Department of Surgery at Cedars-Sinai Cristina Ferrone
#gensurgmatch2024

Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive #cholangiocarcinoma

Full text here👉journal-of-hepatology.eu/article/S0168-…

Timothy DiPeri, MD
MD Anderson Cancer Center
#LiverTwitter

#OpenAccess in Cancer Discovery from Dr. Funda Meric MD Anderson Cancer Center
Co-Clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts
aacrjournals.org/cancerdiscover…
This study also found MET amplification as a resistance mechanism to Her-2 bispecifics. Good…

Excited to share our new study in Cancer Discovery “Co-Clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts”

Thankful for Dr. Funda Meric-Bernstam’s mentorship and our team at MD Anderson
#zanidatamab #her2

MD Anderson Cancer Center Department of Surgery at Cedars-Sinai

✨NEW CONTENT Nature Cancer “The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients”

nature.com/articles/s4301…
rdcu.be/dxoFR

What a privilege it was to learn about living donor liver transplantation from today's Department of Surgery at Cedars-Sinai Grand Rounds speaker Dr. Elizabeth Pomfret! Thank you for your talk and for taking the time to meet with us!
Cc: Irene

“With meaningful clinical activity, this could represent a new treatment option,” says our Dr. Funda Meric-Bernstam of the U.S. FDA granting priority review to trastuzumab deruxtecan for unresectable or metastatic HER2 positive solid tumors. #CancerResearch #EndCancer

🚨 Another tissue agnostic drug coming soon in a clinic near you 👉🏼Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours #PrecisionMedicine astrazeneca.com/media-centre/p…

Today marked the first Department of Surgery at Cedars-Sinai + UCLA Surgery combined Grand Rounds,

We welcomed Patricia L. Turner, MD, MBA, FACS , Executive Director and CEO id American College of Surgeons as our Jonathan Hiatt Invited Lectureship Guest Speaker.

Cedars-Sinai UCLA Health Cedars-Sinai Gen Surg Residents UCLA SurgeryRes

Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer dlvr.it/T19FLH

Thank you Jason Sicklick #SurgOncClinics for the opportunity to provide an updated review on Pediatric Precision Oncology and the rapidly-expanding clinical application of targeted therapies for pediatric malignancies!

Eugene Kim Department of Surgery at Cedars-Sinai Cedars-Sinai Gen Surg Residents
authors.elsevier.com/a/1iK3z3lyy0qO…

Please join us in congratulating our amazing resident, Dr. William Lee William Lee in receiving the Rosenkrantz Award🏆 at the American Academy of Pediatrics American Academy of Pediatrics! Great work! 👏👏👏

Eugene Kim Cedars-Sinai Gen Surg Residents Cristina Ferrone Cedars-Sinai